Feb 03, 2020 - Check out these three dividend-paying stocks that investors might want to buy to help combat coronavirus-based market pullback fears...
Feb 05, 2020 - Top Research Reports for Netflix, Eli Lilly & United Parcel Service
Feb 06, 2020 - Sanofi (SNY) reports mixed fourth-quarter results with strong Specialty Care and Vaccines sales but soft Consumer Healthcare sales
Feb 07, 2020 - Pricing erosion in U.S. generics market and rapid erosion in sales of Copaxone are likely to have hurt Teva's (TEVA) Q4 sales.
Feb 11, 2020 - Eli Lilly's (LLY) Alzheimer's disease drug, solanezumab, fails to meet primary endpoint in a phase II/III investigator-led study.
Feb 14, 2020 - AbbVie (ABBV) and Allergan (AGN) announce Q4 results.
Dec 02, 2019 - These companies have some important presentations scheduled for the last big oncology conference of the year.
Dec 13, 2019 - This week two deals grab headlines in the pharma space. Merck (MRK) offers to buy ArQule for $2.7 billion while Sanofi (SNY) signs a definitive deal to purchase Synthorx for $2.5 billion
Dec 16, 2019 - Lilly's (LLY) regulatory application seeking approval for cancer drug, Cyramza, in combination with erlotinib for treating EGFR-mutated NSCLC in first-line setting gets positive CHMP opinion for approval in EU.
Dec 17, 2019 - Over the past couple of years, patents have expired on a few of Eli Lilly's (LLY) key drugs, most no